NeurogesX

NeurogesX's CEO Discusses Q2 2012 Results - Earnings Call Transcript
NeurogesX's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Seeking Alpha
earnings
NeurogesX
Flag link:
NeurogesX receives additional notice of allowance covering NGX-1998 in U.S.
NeurogesX receives additional notice of allowance covering NGX-1998 in U.S.
Yahoo/Fly on the Wall
NeurogesX
NGX-1998
Flag link:
NeurogesX Reports First Quarter 2012 Results
NeurogesX Reports First Quarter 2012 Results
Yahoo
earnings
NeurogesX
Flag link:
NeurogesX seeks partners for pain drugs
NeurogesX seeks partners for pain drugs
Reuters
NeurogesX
Qutenza
neuropathic pain
Flag link:
NeurogesX Fails to Win U.S. Approval to Sell Patch for HIV-Related Pain
NeurogesX Fails to Win U.S. Approval to Sell Patch for HIV-Related Pain
Bloomberg
FDA
HIV
NeurogesX
HIV-related pain
Qutenza
Flag link:
Merck, Pfizer, Bristol-Myers, Affymax, Chelsea Therapeutics Face Key Dates in March
Merck, Pfizer, Bristol-Myers, Affymax, Chelsea Therapeutics Face Key Dates in March
Minyanville
Merck
Pfizer
Bristol-Myers Squibb
Chelsea Therapeutics
Affymax
Astex
JNJ
Discovery Labs
Ariad Pharmaceuticals
NeurogesX
Amgen
Flag link:
NeurogesX' Stock Trading Halted Today
NeurogesX' Stock Trading Halted Today
Yahoo
NeurogesX
FDA
Qutenza
pain patches
Flag link:
NeurogesX Shares Plunge After FDA Staff Says Pain Patch Might Not Work
NeurogesX Shares Plunge After FDA Staff Says Pain Patch Might Not Work
Bloomberg
NeurogesX
FDA
pain patches
Qutenza
Flag link:
FDA Pending Catalysts For 5 Biotechs
FDA Pending Catalysts For 5 Biotechs
Seeking Alpha
FDA
Amylin
NeurogesX
Threshold Pharmaceuticals
Astex
Cell Therapeutics
Flag link:
9 Biotech Companies With FDA Approval Decision Dates In Q1 2012
9 Biotech Companies With FDA Approval Decision Dates In Q1 2012
Seeking Alpha
FDA
Fentanyl SL
INSYS Therapeutics
Dapagliflozin
Bristol-Myers Squibb
Prochieve
Columbia Laboratories
Discovery Labs
Surfaxin
NeurogesX
Qutenza
Curis
Roche
vismodegib
Chelsea Therapeutics
Northera
ONYX Pharmaceuticals
Carfilzomib
Flag link:
NeurogesX Reports Positive Phase 2 Results for NGX-1998 for Treatment of Postherpetic Neuralgia
NeurogesX Reports Positive Phase 2 Results for NGX-1998 for Treatment of Postherpetic Neuralgia
Yahoo
NGX-1998
NeurogesX
postherpetic neuralgia
Flag link:
A Myriad of Biotech Catalysts Possible at Rodman & Renshaw 2011
A Myriad of Biotech Catalysts Possible at Rodman & Renshaw 2011
CP Wire
Curis
Rodman & Renshaw
BioSante
Cardium
CytoSorbents
NeurogesX
Supergen
Repros Therapeutics
Flag link:
What Happens After Intermezzo's Likely FDA Approval
What Happens After Intermezzo's Likely FDA Approval
Seeking Alpha
Intermezzo
FDA
Transcept
Somaxon
NeurogesX
Flag link:
NeurogesX soars on drug update
NeurogesX soars on drug update
Marketwatch
NeurogesX
NGX-1998
capsaicin
Flag link:
NeurogesX Q4 loss more than doubles
NeurogesX Q4 loss more than doubles
Bizjournals.com
NeurogesX
earnings
Flag link:
U.S. Pharma: Latest Analyst Actions
U.S. Pharma: Latest Analyst Actions
Seeking Alpha
Seattle Genetics
Incyte
Biodel
Cadence Pharmaceuticals
NeurogesX
Metabolix
Gilead Sciences
Pfizer
Flag link:
What Investors Think About NeurogesX
What Investors Think About NeurogesX
Motley Fool
investors
NeurogesX
Flag link:
[video] Trading Smallcap Biotech
[video] Trading Smallcap Biotech
TheStreet.com
Savient
Medivation
Prolor
Synta
Chelsea Therapeutics
Halozyme
NeurogesX
Flag link:
NeurogesX: Next Stop, U.S. Market
NeurogesX: Next Stop, U.S. Market
Seeking Alpha
Astellas
NeurogesX
Qutenza
Flag link:
NeurogesX receives Food and Drug Administration approval for Qutenza pain patch
NeurogesX receives Food and Drug Administration approval for Qutenza pain patch
Yahoo/AP
FDA
pain patches
Qutenza
NeurogesX
Flag link:

Pages